The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization

被引:44
作者
Leppig, KA
Viskochil, D
Neil, S
Rubenstein, A
Johnson, VP
Zhu, XL
Brothman, AR
Stephens, K
机构
[1] UNIV WASHINGTON, DEPT PEDIAT, DIV MED GENET, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT MED, DIV MED GENET, SEATTLE, WA 98195 USA
[3] UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA
[4] UNIV UTAH, DEPT PEDIAT, SALT LAKE CITY, UT USA
[5] MT SINAI SCH MED, DEPT NEUROL, NEW YORK, NY USA
[6] UNIV S DAKOTA, DEPT OBSTET & GYNECOL, VERMILLION, SD 57069 USA
[7] UNIV S DAKOTA, DEPT PEDIAT, VERMILLION, SD 57069 USA
[8] UNIV S DAKOTA, DEPT LAB MED, VERMILLION, SD 57069 USA
来源
CYTOGENETICS AND CELL GENETICS | 1996年 / 72卷 / 01期
关键词
D O I
10.1159/000134171
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized primarily by the development of multiple neurofibromas and pigmentary changes. The recent identification of contiguous gene deletions in NF1, a previously unrecognized molecular basis for this disorder, raises important questions regarding deletion frequency in the patient population and the role that contiguous genes may play in the physical manifestations of NF1 patients. To facilitate the identification of patients with large NF1 deletions, we have isolated clones carrying large genomic segments from the NF1 locus and tested their efficacy as probes for fluorescence in situ hybridization (FISH). Clone P 1-9 spans approximately 65 kb of the NF 1 gene, including exons 2-11, and clone P1-12 carries similar to 55 kb of NF1 intron 27B. FISH studies performed with P1-9, P1-12, and a set of overlapping 1F10 cosmid clones mapping telomeric to the NF1 locus identified large deletions in two new neurofibromatosis type 1 patients who, like previously characterized deletion patients, had mildly dysmorphic facial features and large numbers of cutaneous neurofibromas.
引用
收藏
页码:95 / 98
页数:4
相关论文
共 21 条
[1]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]   DNA DELETION ASSOCIATED WITH HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES [J].
CHANCE, PF ;
ALDERSON, MK ;
LEPPIG, KA ;
LENSCH, MW ;
MATSUNAMI, N ;
SMITH, B ;
SWANSON, PD ;
ODELBERG, SJ ;
DISTECHE, CM ;
BIRD, TD .
CELL, 1993, 72 (01) :143-151
[3]  
FAIN PR, 1989, AM J HUM GENET, V45, P721
[4]  
GOLDGAR DE, 1989, AM J HUM GENET, V44, P6
[5]   VONRECKLINGHAUSEN NEUROFIBROMATOSIS - A CLINICAL AND POPULATION STUDY IN SOUTHEAST WALES [J].
HUSON, SM ;
HARPER, PS ;
COMPSTON, DAS .
BRAIN, 1988, 111 :1355-1381
[6]  
JORDE LB, 1993, AM J HUM GENET, V53, P1038
[7]  
KAYES LM, 1994, AM J HUM GENET, V54, P424
[8]   LARGE DENOVO DNA DELETION IN A PATIENT WITH SPORADIC NEUROFIBROMATOSIS-1, MENTAL-RETARDATION, AND DYSMORPHISM [J].
KAYES, LM ;
RICCARDI, VM ;
BURKE, W ;
BENNETT, RL ;
STEPHENS, K .
JOURNAL OF MEDICAL GENETICS, 1992, 29 (10) :686-690
[9]  
LEDBETTER DH, 1989, AM J HUM GENET, V44, P20
[10]  
Leppig K. A., 1994, American Journal of Human Genetics, V55, pA229